Integra LifeSciences Holdings Corporation (IART) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 953.27M |
| Enterprise Value | 2.75B |
| P/E Ratio | -2.72 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.83 |
| Price/Book Ratio | 1.3 |
| Enterprise/Revenue | 1.93 |
| Enterprise/EBITDA | -10.96 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.3 |
| Operating Margin | 0.08 |
| Return On Assets | -0.14 |
| Return On Equity | -0.48 |
| Revenue | 1.64B |
| Revenue/Share | 21.37 |
| Gross Profit | 845.23M |
| EBITDA | -326.2M |
| Net Income | -516.47M |
| Diluted EPS | -6.73 |
| Total Cash | 265.5M |
| Total Cash/Share | 3.45 |
| Total Debt | 2.04B |
| Total Debt/Equity | 1.96 |
| Current Ratio | 3.38 |
| Book Value Per Share | 13.55 |
| 52-Week Change | 51.46 |
| 52-Week High | 18.3 |
| 52-Week Low | 8.7 |
| Moving Average 50 Days | 14.02 |
| Moving Average 200 Days | 12.79 |
| Average Volume | 974,204 |
| Shares Outstanding | 77.8M |
| % Held by Institutions | 97.45 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | January 04, 2017 |